Hussain Bilal, Mahmood Ahmed, Flynn Michael G, Alexander Thomas
The Brooklyn Hospital Center, Brooklyn, NY.
Corpus Christi Medical Center, Corpus Christi, TX.
HCA Healthc J Med. 2023 Oct 30;4(5):341-352. doi: 10.36518/2689-0216.1565. eCollection 2023.
Coronary artery calcium (CAC) scoring is an important prognostic tool for personalized cardiovascular preventive care and has recently been incorporated into American College of Cardiology/American Heart Association guidelines. CAC provides direct visualization and quantification of CAC burden for risk stratification and primary prevention of cardiovascular events in an asymptomatic population. CAC scoring is recommended for individuals with intermediate 10-year atherosclerotic cardiovascular disease (ASCVD) risk and selective populations with borderline ASCVD risk. In this review, we outline the interpretation of CAC scores for predicting the risk of cardiovascular events, and we highlight the guidelines for starting statin and potentially starting aspirin therapy. A CAC score of 0 is the strongest negative predictive factor for cardiovascular disease (CVD), and a 0 score can successfully de-risk a patient. On the contrary, higher CAC scores correlate with worse cardiovascular prognostic outcomes. The CAC scan is a widely available and reproducible means for an early look at the atherosclerotic burden, and it can help strategize early interventions. The CAC interpretation and the decision to start treatment need to be personalized based on individual risk factors. We believe the emerging literature supports our contention that the CAC score can be used more broadly to improve the prophylaxis and treatment of a wider range of apparently healthy patients.
冠状动脉钙化(CAC)评分是个性化心血管疾病预防护理的一项重要预后工具,最近已被纳入美国心脏病学会/美国心脏协会的指南。CAC能够直接可视化并量化钙化负担,用于无症状人群的风险分层和心血管事件的一级预防。对于10年动脉粥样硬化性心血管疾病(ASCVD)风险处于中等水平的个体以及ASCVD风险处于临界状态的特定人群,建议进行CAC评分。在本综述中,我们概述了用于预测心血管事件风险的CAC评分的解读,并着重介绍了启动他汀类药物治疗以及可能启动阿司匹林治疗的指南。CAC评分为0是心血管疾病(CVD)最强的阴性预测因子,评分为0可成功降低患者的风险。相反,较高的CAC评分与更差的心血管预后相关。CAC扫描是一种广泛可用且可重复的方法,用于早期了解动脉粥样硬化负担,它有助于制定早期干预策略。需要根据个体风险因素对CAC解读和启动治疗的决策进行个性化。我们认为,新出现的文献支持我们的观点,即CAC评分可更广泛地用于改善对更多看似健康患者的预防和治疗。